Needle Free Injections Analysis of Pipeline Product, Major Players, and Pipeline

Posted by Deeksha on June 6th, 2019

The following research report is a compilation of high-end data that has been researched thoroughly to highlight the various trends prevailing across the Needle Free Injections. This study is titled “Needle Free Injections” - Medical Devices Pipeline Assessment, 2019, which carefully examines several vital factors such as market share, market revenue, market dynamics and competitive scenario active in the target market for the period 2019

Request Sample Copy of the Report @

Needle Free Injections - Medical Devices Pipeline Assessment, 2019

GlobalData's Medical Devices sector report, Needle Free Injections - Medical Devices Pipeline Assessment, 2019" provides an overview of Needle Free Injections currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Needle Free Injections pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

- Extensive coverage of the Needle Free Injections under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Needle Free Injections and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy
The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Needle Free Injections under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date.

Browse Full Report with TOC@

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Needle Free Injections Overview
3 Products under Development
3.1 Needle Free Injections - Pipeline Products by Stage of Development
3.2 Needle Free Injections - Pipeline Products by Territory
3.3 Needle Free Injections - Pipeline Products by Regulatory Path
3.4 Needle Free Injections - Pipeline Products by Estimated Approval Date
3.5 Needle Free Injections - Ongoing Clinical Trials
4 Needle Free Injections - Pipeline Products under Development by Companies
4.1 Needle Free Injections Companies - Pipeline Products by Stage of Development
4.2 Needle Free Injections - Pipeline Products by Stage of Development
5 Needle Free Injections Companies and Product Overview
5.1 B. Braun Melsungen AG Company Overview
5.2 Boston Scientific Corp Company Overview
5.3 Crossject SA Company Overview
5.4 Enable Injections Inc Company Overview
5.5 Enesi Pharma Ltd Company Overview
5.6 Eternity Healthcare Inc. Company Overview
5.7 Inovio Pharmaceuticals Inc Company Overview
5.8 Medical International Technologies (Mit Canada) Inc Company Overview
5.9 PharmaJet Inc Company Overview
5.10 Queen's University Company Overview
5.11 Takeda Pharmaceutical Co Ltd Company Overview
5.12 Teva Pharmaceutical Industries Ltd Company Overview
6 Needle Free Injections- Recent Developments
6.1 May 02, 2019: Antares Pharma reports first quarter 2019 operating and financial results
6.2 May 02, 2019: Teva reports first quarter 2019 financial results
6.3 Apr 30, 2019: Merck announces first-quarter 2019 financial results
6.4 Apr 25, 2019: Baxter reports first-quarter 2019 results
6.5 Apr 24, 2019: Boston Scientific announces results for first quarter 2019
6.6 Apr 10, 2019: Enesi Pharmas ImplaVax platform shortlisted for Best New Vaccine Technology/Platform at the Vaccine Industry Excellence (ViE) Awards 2019
6.7 Apr 10, 2019: Teva signs new .3 billion syndicated revolving credit facility
6.8 Mar 29, 2019: Daiichi Sankyo announces chief executive officer (CEO) change
6.9 Mar 05, 2019: Valeritas announces fourth quarter and full year 2018 financial results
6.10 Mar 04, 2019: Antares Pharma announces board changes



Like it? Share it!


About the Author

Joined: January 3rd, 2019
Articles Posted: 12,334

More by this author